UNSPSC 51282135: Pivampicillin hydrochloride

This classification denotes a penicillin antibiotic with the molecular formula C22H29N3O6S.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V9HOC53L7L, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, monohydrochloride, (2s-(2alpha,5alpha,6beta(s*)))- but more generally known as pivampicillin hydrochloride, which bears US NIH Compound Identifier 33477.

UNSPSC 51282135 Pivampicillin hydrochloride is a Commodity code for a specific antibiotic pharmaceutical product, but the recent state and local opportunities posted under this code do not reflect procurement of pivampicillin itself. Instead, the solicitations tagged to this code are purchasing other pharmaceutical products — antibiotic tablets (Doxycycline Hyclate and Ciprofloxacin Hydrochloride) and naloxone with drug deactivation systems — suggesting a mismatch between the code designation and actual procurement scope. State and local purchasing offices are using this code to tag broader pharmaceutical supply and warehouse orders through cooperative purchasing vehicles and competitive bids, rather than sourcing the specific antibiotic named in the code's definition.

Recent activity shows issuing bodies including state health departments and county government purchasing naloxone, opioid-reversal products, and other pharmaceutical supplies through IFBs and piggyback cooperative contracts. The Illinois Department of Public Health awarded a $2,999,999.11 pharmaceutical warehouse piggyback contract through MMCAP Infuse to Chartwell Rx LLC in August 2026 (completed award, not an open solicitation), while Seminole County, Florida released an IFB in June 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023 (note: the due date in the source appears inconsistent). The geographic spread reflects at least Illinois and Florida activity, with procurement structured around cooperative purchasing consortia and county health initiatives. The lack of direct relevance between the code name and actual solicitation scope suggests this code has limited utility for pursuing pivampicillin-specific opportunities in state and local markets.